New device is more effective and safer than FDA-approved treatment for acute stroke patients
« Back to Article
A cerebral blood clot being aspirated from the body after capture by the Solitaire (Image: Covidien)
Angiogram of cerebral blood vessel blocked by clot (Image: Covidien)
Angiogram of cerebral blood vessel after Solitaire treatment (Image: Covidien)
Open end of the Solitaire Revascularization Device. The three caps are x-ray markers which assist in locating the end of the Solitaire in use (Image: Covidien)
A cerebral blood clot captured by the Solitaire Revascularization Device (Image: Covidien)
The Solitaire Revascularization Device in use (Image: Covidien)
A cerebral blood clot captured by the Solitaire Revascularization Device (Image: Covidien)
Article Summary
A new approach to stroke treatment initially developed by Dr. Jeffrey Saver's group at the UCLA Stroke Center combines the ability to restore circulation and remove clots using only a single device ... and it's showing significant promise in trials. In a study comparing the Covidien Solitaire FR Revascularization Device with the FDA-approved Merci Retriever, the device successfully and safely treated roughly 60 percent of stroke patients, compared to roughly 30 percent when the Merci Retriever was used.
« Back to New device is more effective and safer than FDA-approved treatment for acute stroke patients
Other Images from this Gallery
Related Articles
-
Clot removal tool extends treatment window for stroke victims
21st June, 2010
-
Single-player chess hones your skills
23rd November, 2010
-
Tamago play furniture: 100% recyclable for 100% fun
16th June, 2009
-
Brain vacuum technique reverses the effects of stroke
10th June, 2010
-
Head patch measures blood flow in stroke patients' brains
3rd February, 2012
-
FDA approves the treatment of brain tumors with electrical fields
13th February, 2012
